CXCR4 and ovarian cancer: (1) Optimization of chemotaxis and penetration capabilities: CAR-NK cells engineered to overexpress CXCR4 exhibited a tenfold increase in ovarian cancer tissue migration efficiency by targeting CXCL12 chemokine gradients.